I thought this too, until someone in finance told me to google “Theranos Board of Directors”, so I did, and it looked a lot like OpenAI’s new board.
This provides an alternate hypothesis: That signals nothing substantial. Perhaps it’s empty credentialism, or empty PR, or a cheap attempt to win military contacts.
I thought this too, until someone in finance told me to google “Theranos Board of Directors”, so I did, and it looked a lot like OpenAI’s new board.
This provides an alternate hypothesis: That signals nothing substantial. Perhaps it’s empty credentialism, or empty PR, or a cheap attempt to win military contacts.